3C
HCAT icon

361 Capital’s Health Catalyst HCAT Stock Holding History

361 Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$688K Sell
23,599
-3,683
-13% -$102K 0.32% 163
2020
Q1 		$713K Buy
+27,282
New +$834K 0.32% 145

Other funds holding HCAT

NVPX
Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

361 Capital's HCAT Position: Q2 2020 in Review

361 Capital reduced its Health Catalyst (HCAT) stake by 13% in Q2 2020, selling an estimated $102K and leaving 23,599 shares worth $688K. The position accounts for 0.32% of the portfolio, ranked #163.

361 Capital first reported a position in HCAT in Q1 2020 and has held it in 2 quarters since. The position peaked at $713K in Q1 2020. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2020.

  • 361 Capital held 23,599 shares of Health Catalyst worth $688K as of Q2 2020.
  • 361 Capital sold 3,683 Health Catalyst shares in Q2 2020, an estimated $102K.
  • Health Catalyst made up 0.32% of 361 Capital's portfolio in Q2 2020, its #163 holding.
  • 361 Capital first reported a position in Health Catalyst in Q1 2020 and has held it in 2 quarters since.
  • 361 Capital's Health Catalyst position peaked at $713K in Q1 2020.
  • 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.